HC Wainwright Lowers Outlook Therapeutics (NASDAQ:OTLK) Price Target to $3.00
Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) had its target price decreased by HC Wainwright from $30.00 to $3.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 76.99% from the company’s previous close. HC Wainwright also issued […]
Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) had its target price decreased by HC Wainwright from $30.00 to $3.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 76.99% from the company’s previous close. HC Wainwright also issued […]
